Semaglutide

Semaglutide – GLP‑1 Receptor Agonist Research Peptide

Short Description: Semaglutide is a synthetic GLP‑1 receptor agonist studied for its role in glucose regulation, energy homeostasis, and metabolic signaling in controlled in‑vitro research.

Semaglutide is a synthetic GLP‑1 receptor agonist used in laboratory research to investigate glucose regulation, energy balance, and cellular signaling pathways. With its strong affinity for the GLP‑1 receptor, Semaglutide is a key model compound in metabolic and endocrine research focused on peptide‑receptor interactions and downstream metabolic effects.

Our Semaglutide is produced in controlled laboratory environments and verified using High‑Performance Liquid Chromatography (HPLC) to ensure a purity of ≥99%. Each batch is supplied as a stable lyophilized powder, ideal for research requiring high accuracy, consistency, and reproducibility.

Key Specifications

• Product Name: Semaglutide (GLP‑1 analogue)
• Molecular Formula: C187H291N45O59
• Molecular Weight: ≈4,113.6 Da
• Purity: ≥99% (HPLC tested)
• Form: Lyophilized Powder
• Storage: Store refrigerated; protect from light and moisture
• Use Type: Exclusively for in‑vitro research purposes
• COA / Test Report: Available upon request

Research Applications & Benefits

• Serves as a primary model in GLP‑1 receptor signaling studies.
• Supports in‑vitro research on glucose metabolism and hormonal energy processes.
• Widely used in labs examining metabolic regulation and endocrine pathways.
• Relevant for research into energy balance and weight‑regulation mechanisms.

For research use only. Not for human or veterinary use.